Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 185 | $108,779,057 |
Sells | 4 | $198,660,583 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 646 | 167.63 | 108,289 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 579 | 183.3999 | 106,189 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 683 | 153.9736 | 105,164 | I |
23 Oct 2023 16:49 | BCEL | Atreca Inc | BAKER BROS. ADVISORS LP | Former 10% Owner | 19 Oct 2023 | Sale | 251,902 | 0.4025 | 101,391 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 446 | 224.9117 | 100,311 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 646 | 152.2129 | 98,330 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 22 May 2023 | Purchase | 3,781 | 24.8 | 93,769 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 143,519 | 0.6308 | 90,532 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 363 | 223.9374 | 81,289 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 361 | 221.7787 | 80,062 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 461 | 171.79 | 79,195 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 360 | 219.8652 | 79,151 | I |
28 Mar 2024 19:04 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 27 Mar 2024 | Purchase | 8,439 | 9.2673 | 78,207 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 537 | 145.4592 | 78,112 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 352 | 220.6546 | 77,670 | I |
28 Mar 2024 19:04 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 28 Mar 2024 | Purchase | 8,066 | 9.6194 | 77,590 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 507 | 152.48 | 77,307 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 370 | 208.6913 | 77,216 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 405 | 187.345 | 75,875 | I |
15 Dec 2023 17:32 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 14 Dec 2023 | Purchase | 11,621 | 6.5016 | 75,555 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 415 | 175.7185 | 72,923 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 388 | 187.2707 | 72,661 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 316 | 229.8647 | 72,637 | I |
24 May 2023 17:09 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Director , 10% | 24 May 2023 | Purchase | 2,688 | 25.5138 | 68,581 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 308 | 221.2418 | 68,142 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 369 | 183.16 | 67,586 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 93,091 | 0.6924 | 64,456 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 350 | 173.2016 | 60,621 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 427 | 140.9024 | 60,165 | I |
15 Dec 2023 17:32 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 13 Dec 2023 | Purchase | 9,649 | 5.7588 | 55,567 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 390 | 137.6855 | 53,697 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 229 | 217.9078 | 49,901 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 250 | 189.6978 | 47,424 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 299 | 154.5969 | 46,224 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 311 | 136.9089 | 42,579 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 61,134 | 0.6928 | 42,354 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 185 | 217.9 | 40,312 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 176 | 228.7893 | 40,267 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 185 | 213.625 | 39,521 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 242 | 153.2523 | 37,087 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 252 | 145.9775 | 36,786 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 265 | 136.1805 | 36,088 | I |
15 Dec 2023 17:32 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 13 Dec 2023 | Purchase | 5,679 | 5.9921 | 34,029 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 176 | 187.2439 | 32,955 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 141 | 216.6683 | 30,550 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 153 | 181.93 | 27,835 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 146 | 185.9442 | 27,148 | I |
15 Dec 2023 17:32 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Dec 2023 | Purchase | 4,188 | 6.3661 | 26,661 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 140 | 173.7481 | 24,325 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 107 | 226.971 | 24,286 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 115 | 186.593 | 21,458 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 93 | 209.765 | 19,508 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 93 | 205.32 | 19,095 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 100 | 185.865 | 18,586 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 95 | 188.8359 | 17,939 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 93 | 168.7825 | 15,697 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 109 | 142.8575 | 15,571 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 82 | 174.6698 | 14,323 | I |
28 Mar 2024 19:04 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 27 Mar 2024 | Purchase | 1,543 | 9.2207 | 14,228 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 17,124 | 0.6805 | 11,653 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 56 | 205.6 | 11,514 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 53 | 214.7223 | 11,380 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 52 | 212.0414 | 11,026 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 52 | 206.9321 | 10,760 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 53 | 186.3171 | 9,875 | I |
23 Oct 2023 16:49 | BCEL | Atreca Inc | BAKER BROS. ADVISORS LP | Former 10% Owner | 19 Oct 2023 | Sale | 22,837 | 0.4025 | 9,192 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 54 | 167.63 | 9,052 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 41 | 213.7994 | 8,766 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 54 | 152.2129 | 8,219 | I |
28 Mar 2024 19:04 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 27 Mar 2024 | Purchase | 761 | 9.2673 | 7,052 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 39 | 171.79 | 6,700 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 29 | 223.9374 | 6,494 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 30 | 208.6913 | 6,261 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 31 | 183.16 | 5,678 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 7,676 | 0.6924 | 5,315 | I |
15 Dec 2023 17:32 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 13 Dec 2023 | Purchase | 769 | 5.7588 | 4,429 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 5,041 | 0.6928 | 3,492 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 15 | 217.9 | 3,268 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 15 | 213.625 | 3,204 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 4,434 | 0.6828 | 3,028 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 4,342 | 0.665 | 2,887 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 12 | 185.9442 | 2,231 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 7 | 209.765 | 1,468 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 7 | 205.32 | 1,437 | I |
15 Dec 2023 17:32 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Dec 2023 | Purchase | 185 | 6.355 | 1,176 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 366 | 0.6828 | 250 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 358 | 0.665 | 238 | I |
15 Dec 2023 17:32 | IGMS | IGM Biosciences Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Dec 2023 | Purchase | 15 | 6.355 | 95 | I |
22 Aug 2024 16:03 | KYMR | Kymera Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | 20 Aug 2024 | Purchase | 1 | 46.41 | 46 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)